Hilde Steineger is the founder of NorthSea Therapeutics. NorthSea Therapeutics has raised $68M in total funding. Latest round: Series C.
Hilde Steineger is a biotechnology executive with experience in financial analysis, venture capital, and business development. She is a co-founder and former Chief Operating Officer of NorthSea Therapeutics, a late-stage biopharmaceutical company. She has also served as CEO of Staten Biotechnology where she led a $480M deal with Novo Nordisk.
Full founder directory · Investor directory · Company funding database · Fundraising library